Used primarily in the treatment of protozoal and anaerobic bacterial infections, this compound serves as a prodrug that is activated within microbial cells to exert cytotoxic effects. It is particularly effective against organisms responsible for gastrointestinal and systemic infections. Due to its enhanced stability and absorption profile, it is employed in formulations designed for improved bioavailability compared to related nitroimidazole derivatives. Its application is mainly found in veterinary medicine and under investigation for specific human therapeutic uses, especially in regions where resistant strains limit treatment options.